Supporting this, iPSC neurons from PD patients show altered NAD+ metabolism with imbalanced NAD+/NAM ratios (Schondorf et al. 2018) similar to those reported for Cd38 knockout mice. This evidence concerns the gene CD38 and Parkinson disease.